Radojka M Savic1, Maria C Kjellsson, Mats O Karlsson. 1. Division of Pharmacokinetics and Drug Therapy, Department of Pharmaceutical Biosciences, Faculty of Pharmacy, Uppsala University, Uppsala, Sweden. Rada.Savic@farmbio.uu.se
Abstract
PURPOSE: In NONMEM VI, a novel method exists for estimation of a nonparametric parameter distribution. The parameter distributions are approximated by discrete probability density functions at a number of parameter values (support points). The support points are obtained from the empirical Bayes estimates from a preceding parametric estimation step, run with the First Order (FO) or First Order Conditional Estimation (FOCE) methods. The purpose of this work is to evaluate this new method with respect to parameter distribution estimation. METHODS: The performance of the method, with special emphasis on the analysis of data with non-normal distribution of random effects, was studied using Monte Carlo (MC) simulations. RESULTS: The mean value (and ranges) of absolute relative biases (ARBs, %) in parameter distribution estimates with nonparametric methods preceded with FO and FOCE were 0.80 (0.1-3.7) and 0.70 (0-3), respectively, while for parametric methods, these values were 23.74 (3.3-97.5) and 4.38 (0.1-17.9), for FO and FOCE, respectively. The nonparametric estimation method in NONMEM could identify non-normal parameter distributions and correct bias in parameter estimates seen when applying the FO estimation method. CONCLUSIONS: The method shows promising properties when analyzing different types of pharmacokinetic (PK) data with both the FO and FOCE methods as preceding steps.
PURPOSE: In NONMEM VI, a novel method exists for estimation of a nonparametric parameter distribution. The parameter distributions are approximated by discrete probability density functions at a number of parameter values (support points). The support points are obtained from the empirical Bayes estimates from a preceding parametric estimation step, run with the First Order (FO) or First Order Conditional Estimation (FOCE) methods. The purpose of this work is to evaluate this new method with respect to parameter distribution estimation. METHODS: The performance of the method, with special emphasis on the analysis of data with non-normal distribution of random effects, was studied using Monte Carlo (MC) simulations. RESULTS: The mean value (and ranges) of absolute relative biases (ARBs, %) in parameter distribution estimates with nonparametric methods preceded with FO and FOCE were 0.80 (0.1-3.7) and 0.70 (0-3), respectively, while for parametric methods, these values were 23.74 (3.3-97.5) and 4.38 (0.1-17.9), for FO and FOCE, respectively. The nonparametric estimation method in NONMEM could identify non-normal parameter distributions and correct bias in parameter estimates seen when applying the FO estimation method. CONCLUSIONS: The method shows promising properties when analyzing different types of pharmacokinetic (PK) data with both the FO and FOCE methods as preceding steps.
Authors: Sook Wah Yee; Anh Nguyet Nguyen; Chaline Brown; Radojka M Savic; Youcai Zhang; Richard A Castro; Cheryl D Cropp; Ji Ha Choi; Diment Singh; Harunobu Tahara; Sophie L Stocker; Yong Huang; Claire M Brett; Kathleen M Giacomini Journal: J Pharm Sci Date: 2013-05-06 Impact factor: 3.534
Authors: Max Taubert; Natalie Ebert; Peter Martus; Markus van der Giet; Uwe Fuhr; Elke Schaeffner Journal: Sci Rep Date: 2018-12-07 Impact factor: 4.379
Authors: Walter M Yamada; Michael N Neely; Jay Bartroff; David S Bayard; James V Burke; Mike van Guilder; Roger W Jelliffe; Alona Kryshchenko; Robert Leary; Tatiana Tatarinova; Alan Schumitzky Journal: Pharmaceutics Date: 2020-12-30 Impact factor: 6.321
Authors: Femke de Velde; Brenda C M de Winter; Michael N Neely; Walter M Yamada; Birgit C P Koch; Stephan Harbarth; Elodie von Dach; Teun van Gelder; Angela Huttner; Johan W Mouton Journal: Clin Pharmacokinet Date: 2020-07 Impact factor: 6.447